Literature DB >> 31076375

Diagnostic yield of the SharkCore EUS-guided fine-needle biopsy.

Megan J Fitzpatrick1, Yasmin Genevieve Hernandez-Barco2, Kumar Krishnan2, William Brugge2, Brenna Casey2, Martha B Pitman3.   

Abstract

INTRODUCTION: Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) is the standard diagnostic procedure for many intrathoracic and intra-abdominal lesions. Next-generation fine-needle biopsies (FNBs) can increase diagnostic yield by procuring tissue suitable for histological processing. We evaluate the diagnostic yield and operating characteristics of the SharkCore (SC; Medtronic Corp., Minneapolis, MN) FNB in a tertiary referral facility.
MATERIALS AND METHODS: We performed a single-center retrospective review of SC-FNB-acquired tissue between January 2014 and March 2018. Patient demographic data, endoscopic features, and pathology data were obtained from the electronic medical record. Diagnostic yield was assessed by the ability to obtain a definitive diagnosis, defined as malignant or benign interpretations. Operating characteristics were also calculated.
RESULTS: A total of 179 lesions were sampled with the SC-FNB in 157 patients (mean age: 63 years, 57% male). Of these, 31 lesions were concomitantly sampled with a conventional FNA needle. Most lesions were pancreatic (49%). Diagnostic yield was 86%, which was independent of lesion location, lesion size and needle gauge. Diagnostic accuracy was highest when both histology and cytology specimens were analyzed concurrently (96.5%). In patients with a history of chronic pancreatitis, accuracy, sensitivity, and negative predictive value were reduced (71.4%, 20.0%, and 69.2%, respectively). Rapid onsite evaluation (ROSE) occurred in 64.8% of cases and was more likely to be diagnostic at the time of rapid evaluation if SC-acquired tissue was utilized versus FNA-acquired tissue (P = 0.03); however, final diagnostic yield did not differ between needles (P = 0.13).
CONCLUSIONS: SC-FNB shows high diagnostic yield and accuracy and provides diagnostic tissue for ROSE. SC-FNB is an effective alternative to conventional FNA.
Copyright © 2019 American Society of Cytopathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endoscopic ultrasound; Fine needle biopsy; Fine-needle aspiration; SharkCore

Mesh:

Year:  2019        PMID: 31076375     DOI: 10.1016/j.jasc.2019.03.001

Source DB:  PubMed          Journal:  J Am Soc Cytopathol        ISSN: 2213-2953


  5 in total

1.  Performance of EUS-FNB in solid pancreatic masses: a lesson from 463 consecutive procedures and a practical nomogram.

Authors:  Nico Pagano; Claudio Ricci; Carlo Ingaldi; Sinan Sadalla; Andrea Fabbri; Laura Alberici; Giovanna Impellizeri; Socrate Pallio; Rocco Maurizio Zagari; Antonio De Leo; Matteo Cescon; Riccardo Casadei
Journal:  Updates Surg       Date:  2021-10-29

Review 2.  Architectural aspects of cell-blocks as small biopsies.

Authors:  Swati Satturwar; Liron Pantanowitz
Journal:  Cytojournal       Date:  2021-03-04       Impact factor: 2.091

3.  The value of concurrent endoscopic ultrasound-guided fine needle aspirates and needle core biopsies in the diagnosis of pancreatic neoplasms.

Authors:  Suzanne M Selvaggi
Journal:  Diagn Cytopathol       Date:  2022-07-23       Impact factor: 1.390

4.  Accuracy and clinical outcomes of pancreatic EUS-guided fine-needle biopsy in a consecutive series of 852 specimens.

Authors:  Mikkel Marschall Thomsen; Michael Hareskov Larsen; Tina Di Caterino; Gitte Hedegaard Jensen; Michael Bau Mortensen; Sönke Detlefsen
Journal:  Endosc Ultrasound       Date:  2022-06-08       Impact factor: 5.275

Review 5.  Left-sided portal hypertension caused by peripancreatic lymph node tuberculosis misdiagnosed as pancreatic cancer: a case report and literature review.

Authors:  Dajun Yu; Xiaolan Li; Jianping Gong; Jinzheng Li; Fei Xie; Jiejun Hu
Journal:  BMC Gastroenterol       Date:  2020-08-18       Impact factor: 3.067

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.